Cero Therapeutics Holdings Inc (CERO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,438 | -668 | -405 | -490 | -378 |
| Depreciation Amortization | 274 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 478 | N/A | N/A | N/A | N/A |
| Other Working Capital | 663 | 2,412 | 959 | 237 | 97 |
| Other Operating Activity | -413 | -2,837 | -1,273 | -292 | -27 |
| Operating Cash Flow | $-1,437 | $-1,092 | $-719 | $-545 | $-308 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -325 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 181,164 | 129 | 0 | 0 |
| Investing Cash Flow | $N/A | $180,839 | $129 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 650 | N/A | N/A | N/A |
| Common Stock Issued | 5 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | -139,354 | N/A | N/A | N/A |
| Financing Cash Flow | $5 | $-138,704 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 6,820 | 1,099 | 1,099 | 1,099 | 1,099 |
| End Cash Position | 5,388 | 42,142 | 508 | 554 | 791 |
| Net Cash Flow | $-1,432 | $41,043 | $-591 | $-545 | $-308 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,437 | -1,092 | -719 | -545 | -308 |
| Free Cash Flow | -1,437 | -1,092 | -719 | -545 | -308 |